Core Viewpoint - Perfect Medical (01830) anticipates a shareholder profit of approximately HKD 93 million to HKD 98 million for the six months ending September 30, 2025, compared to HKD 141 million for the six months ending September 30, 2024, indicating a significant growth trajectory in profitability [1] Financial Performance - The expected shareholder profit for the period ending September 30, 2025, is projected to be between HKD 93 million and HKD 98 million [1] - For the six months ending September 30, 2024, the recorded shareholder profit was HKD 141 million [1] - The anticipated profit for the period ending September 30, 2025, represents an increase of at least 40% compared to the approximately HKD 66 million profit recorded in the second half of the 2025 fiscal year [1]
完美医疗发盈警 预计中期股东应占溢利约9300万港元至9800万港元 同比减少